The impact of the Canadian Hypertension Education Programme in its first decade

European Heart Journal

Volumn 30, Issue 12, 2009, Pages 1434-1439

  McAlister, Finlay A ^a   Feldman, Ross D ^b   Wyard, Katherine ^c   Brant, Rollin ^d   Campbell, Norman R C ^e  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CANADA; DIABETIC HYPERTENSION; DRUG USE; EVIDENCE BASED MEDICINE; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HYPERTENSION; NOTE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

AGED; ANTIHYPERTENSIVE AGENTS; CANADA; FEMALE; HEALTH PROMOTION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; RISK REDUCTION BEHAVIOR; STROKE;

EID: 67651092334     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp192     Document Type: Note

References (25)

1. Lawes CMM, Vander Hoorn S, Rodgers A, for the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513-1518.
2. Lawes CMM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. J Hypertens 2006; 24:423-430.
3. Hemmelgarn BR, Chen G, Walker R, McAlister FA, Quan H, Tu K, Khan N, Campbell N. Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol 2008; 24:507-511.
4. Tu K, Chen Z, Lipscombe LL, for the Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. Can Med Assoc J 2008; 178:1429-1435.
5. Tu K, Chen Z, Lipscombe LL, for the Canadian Hypertension Education Program Outcomes Research Taskforce. Mortality among patients with hypertension from 1995-2005: a population-based study. Can Med Assoc J 2008; 178:1436-1440.
6. Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyffier F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45:907-913.
7. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials. Br Med J 2008; 336:1121-1123.
8. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. Br Med J 1998; 317:167-171.
9. McAlister FA, Teo KK, Lewanczuk RZ, Wells G, Montague TJ. Contemporary practice patterns in the management of newly diagnosed hypertension. Can Med Assoc J 1997; 157:23-30.
10. McAlister FA. The Canadian Hypertension Education Program (CHEP) - a unique Canadian initiative. Can J Cardiol 2006; 22:559-564.
11. Drouin D, Campbell NR, Kaczorowski J. Implementation of recommendations on hypertension: the Canadian Hypertension Education Program. Can J Cardiol 2007; 22:595-598.
12. Onysko J, Maxwell C, Eliasziw M, Zhang JX, Johansen H, Campbell NRC, for the Canadian Hypertension Education Program. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension 2006; 48:853-860.
13. Neutel CI, Campbell NRC. Antihypertensive medication use by recently diagnosed hypertensive Canadians. Can J Cardiol 2007; 23:561-565.
14. Campbell NRC, McAlister F, Brant R, Levine M, Drouin D, Feldman R, Herman R, Zarnke K. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens 2003; 21:1591-1597.
15. Campbell NRC, Tu K, Duong-Hua M, Brant R, McAlister FA. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 2006; 47:22-28.
16. Stafford RS, Monti V, Furberg CD, Ma J. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Hypertension 2006; 48:213-218.
17. Muntner P, Krousel-Wood M, Hyre AD, Stanley E, Cushman WC, Cutler JA, Piller LB, Goforth GA, Whelton PK. Antihypertensive prescriptions for newly treated patients before and after publication of the main ALLHAT results and JNC-7 guidelines. Hypertension 2009; 53:617-623.
18. Tu K, Campbell NRC, Duong-Hua M, McAlister FA. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994-2002. Hypertension 2005; 45:1113-1118.
19. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10:1097-1102.
20. Leenen FHH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Lum-Kwong MM, Fodor G. Results of the Ontario Survey on the prevalence and control of hypertension. Can Med Assoc J 2008; 178:1441-1449.
21. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52:818-827.
22. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007; 167:141-147.
23. Campbell NRC, Brant R, Johansen H, Walker R, Wielgosz A, Onysko J, Gao RN, Sambell C, Phillips S, McAlister FA. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009; 53:128-134.
24. Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV. Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001. Can J Cardiol 2003; 19:1359-1366.
25. Lenfant C. Reflections on Hypertension Control Rates. A Message from the Director of the National Heart, Lung, and Blood Institute. Arch Intern Med 2002; 162:131-132.